Qi Deng Selected Research

Qi Deng Research Topics

Disease

15	Neoplasms (Cancer) 08/2023 - 10/2014
9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2023 - 01/2020
8	Cytokine Release Syndrome 01/2024 - 01/2019
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 01/2021
8	Leukemia 12/2023 - 06/2009
7	Inflammation (Inflammations) 01/2024 - 01/2017
6	Lymphoma (Lymphomas) 02/2024 - 06/2019
5	B-Cell Lymphoma (Lymphoma, B Cell) 02/2024 - 10/2014
4	Disease Progression 12/2023 - 02/2018
3	Infections 05/2024 - 08/2015
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2023 - 11/2019
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 11/2020
3	Mycoses (Diseases, Fungus) 10/2021 - 01/2018
2	Brain Diseases (Brain Disorder) 12/2023 - 11/2021
2	Multiple Myeloma 04/2022 - 01/2021
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2022 - 07/2021
2	Residual Neoplasm 01/2022 - 11/2020
2	Hematologic Neoplasms (Hematological Malignancy) 07/2021 - 01/2018
2	Lymphatic Metastasis 03/2021 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 03/2021 - 01/2020
2	Osteosarcoma (Osteogenic Sarcoma) 03/2020 - 01/2019
2	Chondroma (Enchondroma) 01/2019 - 01/2019
2	Tuberculosis (Tuberculoses) 02/2018 - 03/2016
2	Agranulocytosis (Granulocytopenia) 09/2013 - 12/2012
1	Hyperuricemia 04/2024
1	Cytopenia 01/2024
1	Pneumonia (Pneumonitis) 12/2023
1	Coinfection 12/2023
1	Pathologic Constriction (Stenosis) 12/2023
1	Necrosis 09/2023
1	Mesothelioma 08/2023
1	Poisoning 05/2023
1	Shock 01/2023
1	HIV Infections (HIV Infection) 01/2023
1	Hyperglycemia 12/2022
1	Nervous System Diseases (Neurological Disorders) 12/2022
1	Liver Diseases (Liver Disease) 11/2022
1	Ataxia (Dyssynergia) 01/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022
1	Breast Neoplasms (Breast Cancer) 11/2021

Drug/Important Bio-Agent (IBA)

22	Chimeric Antigen ReceptorsIBA 02/2024 - 01/2019
6	Proteins (Proteins, Gene)FDA Link 11/2022 - 08/2014
4	ibrutinibIBA 03/2022 - 11/2020
3	Interleukin-6 (Interleukin 6)IBA 01/2024 - 02/2022
3	CytokinesIBA 12/2023 - 06/2009
2	Polysaccharides (Glycans)IBA 01/2024 - 08/2014
2	Agammaglobulinaemia Tyrosine KinaseIBA 07/2023 - 01/2022
2	Immune Checkpoint InhibitorsIBA 04/2023 - 01/2020
2	Antigen Receptors (Antigen Receptor)IBA 04/2023 - 01/2022
2	Volatile Fatty AcidsIBA 02/2023 - 02/2022
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 04/2022 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2022 - 06/2009
2	Annexin A7 (Synexin)IBA 03/2021 - 01/2020
2	JNK Mitogen-Activated Protein KinasesIBA 03/2021 - 01/2020
2	LigandsIBA 01/2020 - 02/2016
2	Messenger RNA (mRNA)IBA 06/2019 - 10/2014
2	EnzymesIBA 01/2018 - 03/2016
1	Urea (Carbamide)FDA LinkGeneric 04/2024
1	Uric Acid (Urate)IBA 04/2024
1	NitrogenIBA 04/2024
1	Butyric Acid (Butanoic Acid)IBA 01/2024
1	Glutamic Acid (Glutamate)FDA Link 01/2024
1	Serotonin (5 Hydroxytryptamine)IBA 01/2024
1	blinatumomabIBA 12/2023
1	6-chloropenicillanic acid S-sulfoxideIBA 12/2023
1	Fluconazole (Zonal)FDA LinkGeneric 09/2023
1	zimberelimabIBA 08/2023
1	Cisplatin (Platino)FDA LinkGeneric 08/2023
1	Pemetrexed (MTA)FDA Link 08/2023
1	Docosahexaenoic AcidsIBA 05/2023
1	Capsaicin (Zostrix)FDA Link 02/2023
1	Broadly Neutralizing AntibodiesIBA 01/2023
1	SpermidineIBA 12/2022
1	Glucose (Dextrose)FDA LinkGeneric 12/2022
1	Protein Hydrolysates FDA Link 11/2022
1	Bispecific AntibodiesIBA 10/2022
1	B7-H1 AntigenIBA 10/2022
1	AntioxidantsIBA 08/2022
1	MycotoxinsIBA 08/2022
1	Interleukin-10 (Interleukin 10)IBA 02/2022
1	Immunoglobulin M (IgM)IBA 02/2022
1	Immunoglobulin G (IgG)IBA 02/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	venetoclaxIBA 01/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	daratumumabIBA 01/2022
1	indium arsenide (InAs)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	zanubrutinibIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 11/2021

Therapy/Procedure

25	Therapeutics 01/2024 - 01/2011
9	Drug Therapy (Chemotherapy) 08/2023 - 01/2011
5	Salvage Therapy 12/2023 - 01/2021
3	Hematopoietic Stem Cell Transplantation 07/2023 - 01/2020
3	Immunotherapy 10/2022 - 06/2009
2	Radiotherapy 01/2021 - 01/2020
1	Highly Active Antiretroviral Therapy (HAART) 05/2024
1	Withholding Treatment 01/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2022
1	Stem Cell Transplantation 01/2022